ArticleJournal of cellular and molecular medicine2026
The SGLT2 Inhibitor Canagliflozin Promotes β-Cell Regeneration and Restores and Stabilises β-Cell Identity in a Polygenic Model of Severe Early-Onset Type 2 Diabetes.
Iuliana Popescu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.